Search Constraints
Search Results
Select an image to start the slideshow
Abnormal dopamine signaling in a mouse model of dystonia
1 of 38
Neurochemical, neuroprotective, and behavioral effects of enhanced
vesicular storage of dopamine
2 of 38
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
3 of 38
Role of parkin in cytoprotection against misfolded SOD1 toxicity
4 of 38
Functional and structural subdomains of the intracellular loop
domain of the GABAAR α1 subunit
5 of 38
Neuroanatomical Substrates for Head Movements in Humans
6 of 38
Regulation of Myelin Proteins and Protection Against Demyelination
by GPR37 Signaling
7 of 38
D1 and D5 dopamine receptor signaling inarea 9 of the Macaca mulatta dorsolateral prefrontalcortex
8 of 38
Neuropharmacology of 3,4-methylenedioxymethamphetamine (MDMA,
"ecstasy") and its stereoisomers
9 of 38
A new mouse model of L-DOPA-responsive dystonia
10 of 38
Role of Glutamate on Dopamine Neurochemistry and the Behavioral
Pharmacology of Cocaine in Squirrel Monkeys
11 of 38
Metabotropic glutamate and adenosine receptors in the monkey
striatopallidal complex and their involvement in Parkinsonism:
Anatomy, physiology, and behavior
12 of 38
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
13 of 38
Oxytocin and affiliative behavior in prairie voles
14 of 38
Serotonin 5-HT2C Receptor-Mediated Modulation of the Behavioral
and Neurochemical Effects of Cocaine in the Squirrel Monkey
15 of 38
Oxytocin modulates distributed immediate early gene expression across forebrain nuclei in male prairie voles
16 of 38
Cell Type-Dependent Activities of the Ubiquitin-Proteasome Systemand Selective Neurodegeneration
17 of 38
Ferritin as a Transgenic MRI Reporter in Mouse Embryonic Stem Cells
18 of 38
Microglial motility under pro-inflammatory conditions in situ:
Relevance to neurodegeneration
19 of 38
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
20 of 38
Effects of pharmacological dopamine β-hydroxylase
inhibition on cocaine-induced behavior and neurochemistry
21 of 38
Moduation of post-synaptic ion channels by CaMKII
22 of 38
Intrinsic and Synaptic Determinants of Spike Timing Revealed by
Phase Response Analyses of a Morphological Globus Pallidus Neuron
Model
23 of 38
Cholinergic Interneurons: Distribution and Synaptic Inputs in the
Primate Putamen
24 of 38
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
25 of 38
Molecular Pathogenesis of DYT1 Dystonia
26 of 38
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
27 of 38
Regulation of Drosophila Synaptic Function and Plasticity by a
Schizophrenia Susceptibility Network.
28 of 38
Subcellular & Subsynaptic Localization of Group IMetabotropic Glutamate Receptors in the Nucleus Accumbens
29 of 38
Ubiquitin C-terminal hydrolase regulation and dysfunction in
neurodegenerative disease pathogenesis
30 of 38
Regulation of Glutamate Transporter and Receptor Function by the
NHERF Scaffolding Proteins
31 of 38
Molecular Pathogenesis of Charcot-Marie-Tooth disease caused by
mutations in SIMPLE
32 of 38
Molecular Basis of NMDA Receptor Allosteric Regulation by New
Subunit-selective Modulators
33 of 38
Microcircuitry of Group IIIMetabotropic Glutamate Receptors (mGluRs) in the Mouse Striatum
34 of 38
Structural Plasticity of GABAergic and Glutamatergic Terminals in the Ventral Motor and Caudal Intralaminar Thalamic Nuclei in MPTP-treated Parkinsonian Monkeys
35 of 38
The study of Hebbian-type repetitive transcranial magnetic stimulation on impaired hand motor function in chronic stroke
36 of 38
Pharmacologically targeting the GABA-A receptors in neurological disease
37 of 38
Direct reprogramming of astrocytes to enhance recovery after stroke
38 of 38